CA2018137A1 - Citrate magnesique de l-carnitine - Google Patents

Citrate magnesique de l-carnitine

Info

Publication number
CA2018137A1
CA2018137A1 CA2018137A CA2018137A CA2018137A1 CA 2018137 A1 CA2018137 A1 CA 2018137A1 CA 2018137 A CA2018137 A CA 2018137A CA 2018137 A CA2018137 A CA 2018137A CA 2018137 A1 CA2018137 A1 CA 2018137A1
Authority
CA
Canada
Prior art keywords
magnesium citrate
carnitine
carnitine magnesium
magnesium
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2018137A
Other languages
English (en)
Other versions
CA2018137C (fr
Inventor
Thomas Scholl
Willibald F. Kohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Publication of CA2018137A1 publication Critical patent/CA2018137A1/fr
Application granted granted Critical
Publication of CA2018137C publication Critical patent/CA2018137C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
CA002018137A 1989-06-14 1990-06-01 Citrate magnesique de l-carnitine Expired - Lifetime CA2018137C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2221/89 1989-06-14
CH222189 1989-06-14

Publications (2)

Publication Number Publication Date
CA2018137A1 true CA2018137A1 (fr) 1990-12-14
CA2018137C CA2018137C (fr) 2000-01-11

Family

ID=4228693

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002018137A Expired - Lifetime CA2018137C (fr) 1989-06-14 1990-06-01 Citrate magnesique de l-carnitine

Country Status (9)

Country Link
US (1) US5071874A (fr)
EP (1) EP0402755B1 (fr)
JP (1) JP3023919B2 (fr)
AT (1) ATE93511T1 (fr)
CA (1) CA2018137C (fr)
DD (1) DD295155A5 (fr)
DE (1) DE59002438D1 (fr)
DK (1) DK0402755T3 (fr)
ES (1) ES2058680T3 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
RU2038077C1 (ru) * 1992-06-26 1995-06-27 Нонна Дмитриевна Кислякова Средство, обладающее адаптогенной активностью
AU1780395A (en) * 1994-05-02 1995-11-09 Omeara (Proprietary) Limited Amino acid, carnitine and magnesium supplementation
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
IT1291126B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
IT1291133B1 (it) * 1997-04-07 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato
IT1291134B1 (it) * 1997-04-08 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato
IT1291143B1 (it) * 1997-04-18 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina
IT1290600B1 (it) * 1997-04-30 1998-12-10 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato
WO2002017735A2 (fr) * 2000-08-29 2002-03-07 Lonza Ag Procede de fabrication d'un melange pouvant etre granule et hydroxycitrate de carnitine et de magnesium
DE10113446A1 (de) 2001-03-19 2002-09-26 Schwarzkopf Gmbh Hans Haarbehandlungsmittel mit Betainen
ITRM20020055A1 (it) * 2002-02-04 2003-08-04 Aldo Fassi Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti
ITMI20030315A1 (it) * 2003-02-21 2004-08-22 Vama Farmacosmetica S R L Sale di carnitina, preliposoma che lo contiene e formulato dermocosmetico per uso topico a base del detto sale di carnitina.
CN101912045B (zh) * 2005-07-05 2013-07-31 隆萨股份公司 生产干肉碱粉末或颗粒的喷雾干燥法
DE102005062360A1 (de) 2005-12-23 2007-06-28 Henkel Kgaa Haarfärbeverfahren
EP1862163A1 (fr) * 2006-05-12 2007-12-05 Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG L-carnitine pour la supression de la cristallisation
EP1854453B1 (fr) * 2006-05-12 2011-02-16 Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG Composition aqueuse avec stabilité au stockage comprenant une composé du magnesium et du L-carnitine
CN101209975B (zh) 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 左旋肉碱富马酸钙及其制备方法与用途
EP2206440A1 (fr) * 2008-12-24 2010-07-14 Taminco Processus de préparation d'une poudre à écoulement libre d'un composé d'ammoniac quaternaire déliquescent
CN102911067A (zh) * 2011-08-04 2013-02-06 广州市奥海生物科技有限公司 左旋肉碱丙酮酸盐及其制备方法与用途
CN102911068A (zh) * 2011-08-04 2013-02-06 广州市奥海生物科技有限公司 左旋肉碱l-苹果酸盐及其制备方法与用途
CN102911069A (zh) * 2011-08-04 2013-02-06 广州市奥海生物科技有限公司 左旋肉碱柠檬酸钙及其制备方法与用途
CN103922949A (zh) * 2014-04-29 2014-07-16 吉林大学 一种亮氨酸鳌合钙粉及加工方法
KR101721145B1 (ko) * 2015-07-29 2017-03-29 제너럴바이오(주) Ｌ-카르니틴 구연산 마그네슘을 포함하는 배변촉진 겸용 다이어트용 식품 조성물
IL261670B (en) * 2018-09-06 2019-06-30 Tudu Holdings Ltd Magnesium-containing formulation and uses thereof
CN111990574A (zh) * 2020-09-18 2020-11-27 内蒙古精晶生物科技有限公司 一种左旋肉碱营养泡腾片

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE23217C (de) * 1900-01-01 F. E. CANDA in New-York Zapfenlager aus Amalgam
FR4608M (fr) * 1965-04-02 1966-11-21
GB1153640A (en) * 1967-04-10 1969-05-29 Soc D Etudes Prod Chimique A Carnitin Salt
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US4172072A (en) * 1977-10-20 1979-10-23 Ashmead H H Buffered enzymatically produced metal proteinates
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1142201B (it) * 1980-06-24 1986-10-08 Sigma Tau Ind Farmaceuti Procedimento per la produzione enzimatica di l-carnitina
JPS57126420A (en) * 1981-01-26 1982-08-06 Eiji Murakami Drug for digestive organ
DE3463261D1 (en) * 1983-12-28 1987-05-27 Sigma Tau Ind Farmaceuti Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
US4855289A (en) * 1984-06-04 1989-08-08 Wester Per O Combination of two active substances
IT1209564B (it) * 1984-06-29 1989-08-30 Magis Farmaceutici Derivati della l-carnitina o di l-acil carnitina.
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4895980A (en) * 1988-01-05 1990-01-23 Mission Pharmacal Company, Inc. Method of manufacturing magnesium potassium citrate
JP3604736B2 (ja) * 1994-06-30 2004-12-22 株式会社トーア 外壁工法
JPH0824889A (ja) * 1994-07-19 1996-01-30 Hitachi Ltd 噴水曝気型水質浄化装置

Also Published As

Publication number Publication date
DK0402755T3 (da) 1993-10-04
DE59002438D1 (de) 1993-09-30
ES2058680T3 (es) 1994-11-01
EP0402755A3 (fr) 1991-01-16
JP3023919B2 (ja) 2000-03-21
CA2018137C (fr) 2000-01-11
EP0402755B1 (fr) 1993-08-25
EP0402755A2 (fr) 1990-12-19
ATE93511T1 (de) 1993-09-15
JPH0324010A (ja) 1991-02-01
US5071874A (en) 1991-12-10
DD295155A5 (de) 1991-10-24

Similar Documents

Publication Publication Date Title
CA2018137A1 (fr) Citrate magnesique de l-carnitine
EP1164132A3 (fr) Omeprazole de magnésium cristallin
AU6431890A (en) New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and the manufacture and use of said compounds
CA2094879A1 (fr) Procede de fabrication de comprimes pour boissons et produits derives
CA2116942A1 (fr) Produit refrigere contenant des morceaux de chocolat, methode et dispositif pour sa production
EP0259139A3 (en) Novel pyridinylpyrimidine derivatives, method for production thereof and a plant disease protectant containing them as the active ingredient
CA2322473A1 (fr) Complexe de calcium et aliment enrichi en calcium
CA2000763A1 (fr) Produit dispersant
CA2171435A1 (fr) Matiere granulaire effervescente et mode de preparation connexe
IL88908A0 (en) 3,5-dihydroxy carboxylic acid and derivatives thereof,a process for the preparation thereof,the use thereof as pharmaceuticals,pharmaceutical products and intermediates
CA2078939A1 (fr) Sels stables de l'acide 5,10-methylenetetrahydrofolique
CA2162470A1 (fr) Comprime a biodisponibilite amelioree, renfermant de l'acide dichloromethylenediphosphonique comme principe actif
CA2083243A1 (fr) Procede de fabrication d'un concentre de thrombine exempt de virus
CA2035841A1 (fr) Presentations orales de sulfate de glucosamine stables a l'entreposage et mode de fabrication
CA2027341A1 (fr) Procede de preparation de l'acide 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylique et ses derives
CA1269671C (fr)
AU3674989A (en) Process for the preparation of 2,6-dichlorodiphenylaminoacetic acid derivatives
EP0432910A3 (en) Process for producing highly pure 2, 6 naphthalene dicarboxylic acid
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
GR3004863T3 (fr)
CA2030344A1 (fr) Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
CA2136071A1 (fr) Compositions d'acide 2-arylpropionique et mode de preparation
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
CA2345006A1 (fr) Nouveaux derives de benzoylguanidine aux proprietes avantageuses, leur procede de production et leur utilisation dans la production de compositions pharmaceutiques
IE810808L (en) Isophthalic acid picolylamide monohydrate

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry